(Last updated : 2022-06-03 11:12:43)
  谷岡 洋亮
   Department     ,
   Position   Assistant Professor with Special Assignment
■ Journal
1. 2022/05 Phase 3 trial of sequential versus combination treatment in colorectal cancer: The C-cubed study  Link
2. 2022/05 Phase II Study of S-1 and Irinotecan Plus Bevacizumab as Second-line Treatment for Patients With Metastatic Colorectal Cancer Resistant to the Fluoropyrimidine-oxaliplatin-cetuximab Regimen  Link
3. 2021/11 Concordance of acquired mutations between metastatic lesions and liquid biopsy in metastatic colorectal cancer  Link
4. 2021/05/12 Hepatectomy Followed by Adjuvant Chemotherapy with 3-Month Capecitabine Plus Oxaliplatin for Colorectal Cancer Liver Metastases 
5. 2021/05 Clinical and epigenetic features of colorectal cancer patients with somatic POLE proofreading mutations  Link
Display all(24)
■ Presentation
1. 2022/03/04 REVIVE試験:ニボルマブの奏効別の救済化学療法の治療効果について  
2. 2022/02/17 A Phase III trial of sequential versus combination in metastatic colorectal cancer: C-Cubed study  
3. 2022/02/17 Fluctuating PD-1 ratio in blood may predict clinical outcome of upper gastrointestinal cancer patients under ICI therapy  
4. 2022/02/17 REVIVE study: An Observational Study in Chemotherapy (CTx) after Nivolumab (NIVO) for Advanced Gastric Cancer (AGC)  
5. 2022/01/21 A randomized phase 3 study of sequential versus combination treatment in first-line chemotherapy for metastatic colorectal cancer: The C-cubed study  
Display all(31)